gadoterate meglumine

FDA Drug Profile — gadoterate meglumine, Gadoterate Meglumine, CLARISCAN, DOTAREM

gadoterate meglumine is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand names including gadoterate meglumine, Gadoterate Meglumine, CLARISCAN. Available dosage forms: injection, injection, solution.

Drug details

Generic Name
gadoterate meglumine
Brand Names
gadoterate meglumine, Gadoterate Meglumine, CLARISCAN, DOTAREM
Application Number
ANDA218073
Sponsor
Slate Run Pharmaceuticals, LLC
NDC Codes
14
Dosage Forms
INJECTION, INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
GADOTERATE MEGLUMINE

Indications and Usage

1 INDICATIONS AND USAGE Clariscan is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. Clariscan is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.